{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:16:12Z","timestamp":1791645372259,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.4158\/ep13254.or","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T22:40:01Z","timestamp":1378507201000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Mody-3: Novel HNF1A Mutation and the Utility of Glucagon-Like Peptide (GLP)-1 Receptor Agonist Therapy"],"prefix":"10.1016","volume":"20","author":[{"given":"Maricor K.","family":"Docena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Faiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Pantalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP13254.OR_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2337\/diacare.13.1.49","article-title":"Scope and heterogeneous nature of MODY","volume":"13","author":"Fajans","year":"1990","journal-title":"Diabetes Care."},{"key":"10.4158\/EP13254.OR_bb0010","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.2337\/dc11-0035","article-title":"MODY: History, genetics, pathophysiology, and clinical decision making","volume":"34","author":"Fajans","year":"2011","journal-title":"Diabetes Care."},{"key":"10.4158\/EP13254.OR_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/beem.2001.0148","article-title":"Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization","volume":"15","author":"Owen","year":"2001","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.4158\/EP13254.OR_bb0020","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.2337\/diacare.25.12.2292","article-title":"Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect","volume":"25","author":"Klupa","year":"2002","journal-title":"Diabetes Care."},{"key":"10.4158\/EP13254.OR_bb0025","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2337\/diab.46.6.1081","article-title":"Novel mutations and a mutational hotspot in the MODY3 gene","volume":"46","author":"Glucksmann","year":"1997","journal-title":"Diabetes."},{"key":"10.4158\/EP13254.OR_bb0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1507\/endocrj.50.491","article-title":"Regulation of pancreatic beta-cell function by the HNF transcription network: Lessons from maturity-onset diabetes of the young (MODY)","volume":"50","author":"Yamagata","year":"2003","journal-title":"Endocr J."},{"key":"10.4158\/EP13254.OR_bb0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/384455a0","article-title":"Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)","volume":"384","author":"Yamagata","year":"1996","journal-title":"Nature."},{"key":"10.4158\/EP13254.OR_bb0040","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/humu.20357","article-title":"Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young","volume":"27","author":"Ellard","year":"2006","journal-title":"Hum Mutat."},{"key":"10.4158\/EP13254.OR_bb0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/EJE-10-0842","article-title":"Genetic and clinical characteristics of patients with HNF1A gene variations from the german-austrian DPV database","volume":"164","author":"Awa","year":"2011","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP13254.OR_bb0050","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1210\/jcem.87.6.8530","article-title":"Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families","volume":"87","author":"Barrio","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13254.OR_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/db07-0859","article-title":"The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3","volume":"57","author":"Bellann\u00e9-Chantelot","year":"2008","journal-title":"Diabetes."},{"key":"10.4158\/EP13254.OR_bb0060","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/hmg\/ddl147","article-title":"Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes","volume":"15","author":"Harries","year":"2006","journal-title":"Hum Mol Genet."},{"key":"10.4158\/EP13254.OR_bb0065","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00125-006-0158-y","article-title":"Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees","volume":"49","author":"Fajans","year":"2006","journal-title":"Diabetologia."},{"key":"10.4158\/EP13254.OR_bb0070","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.2337\/diabetes.52.8.2182","article-title":"Genetic modifiers of the age at diagnosis of diabetes (MODY3) in carriers of hepatocyte nuclear factor-1alpha mutations map to chromosomes 5p15, 9q22, and 14q24","volume":"52","author":"Kim","year":"2003","journal-title":"Diabetes."},{"key":"10.4158\/EP13254.OR_bb0075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s001250050956","article-title":"Hyperexcitability to sulphonylurea in MODY3","volume":"41","author":"S\u00f8vik","year":"1998","journal-title":"Diabetologia."},{"key":"10.4158\/EP13254.OR_bb0080","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1464-5491.2000.00305.x","article-title":"Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes","volume":"17","author":"Pearson","year":"2000","journal-title":"Diabet Med."},{"key":"10.4158\/EP13254.OR_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods."},{"key":"10.4158\/EP13254.OR_bb0090","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting deleterious amino acid substitutions","volume":"11","author":"Ng","year":"2001","journal-title":"Genome Res."},{"key":"10.4158\/EP13254.OR_bb0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00439-004-1252-1","article-title":"Homeodomain revisited: A lesson from diseasecausing mutations","volume":"116","author":"Chi","year":"2005","journal-title":"Hum Genet."},{"key":"10.4158\/EP13254.OR_bb0100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/dna.2005.24.661","article-title":"Functional dissection of the HNF-1alpha transcription factor: A study on nuclear localization and transcriptional activation","volume":"24","author":"Bj\u00f8rkhaug","year":"2005","journal-title":"DNA Cell Biol."},{"key":"10.4158\/EP13254.OR_bb0105","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1097-2765(02)00704-9","article-title":"Diabetes mutations delineate an atypical POU domain in HNF-1alpha","volume":"10","author":"Chi","year":"2002","journal-title":"Mol Cell."},{"key":"10.4158\/EP13254.OR_bb0110","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s001250051025","article-title":"Mutation screening in 18 Caucasian families suggest the existence of other MODY genes","volume":"41","author":"Ch\u00e8vre","year":"1998","journal-title":"Diabetologia."},{"key":"10.4158\/EP13254.OR_bb0115","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1210\/jc.2006-2467","article-title":"Etiology of early-onset type 2 diabetes in Indians: Islet autoimmunity and mutations in hepatocyte nuclear factor 1alpha and mitochondrial gene","volume":"92","author":"Sahu","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13254.OR_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1399-5448.2011.00827.x","article-title":"Comprehensive molecular analysis of japanese patients with pediatric-onset MODY-type diabetes mellitus","volume":"13","author":"Yorifuji","year":"2012","journal-title":"Pediatr Diabetes."},{"key":"10.4158\/EP13254.OR_bb0125","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1210\/jc.2003-030738","article-title":"The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype","volume":"88","author":"Vilsb\u00f8ll","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13254.OR_bb0130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2005.08.019","article-title":"Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice","volume":"521","author":"Ahr\u00e9n","year":"2005","journal-title":"Eur J Pharmacol."},{"key":"10.4158\/EP13254.OR_bb0135","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1464-5491.2009.02753.x","article-title":"Exenatide-a potential role in treatment of HNF1-alpha MODY in obese patients?","volume":"26","author":"Ahluwalia","year":"2009","journal-title":"Diabet Med."},{"key":"10.4158\/EP13254.OR_bb0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1464-5491.2008.02645.x","article-title":"Treatment of HNF1-alpha MODY with the DPP-4 inhibitor Sitagliptin(1)","volume":"26","author":"Lumb","year":"2009","journal-title":"Diabet Med."},{"key":"10.4158\/EP13254.OR_bb0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/dia.2009.0159","article-title":"Dipeptidyl peptidase-IV inhibitors are efficient adjunct therapy in HNF1A maturity-onset diabetes of the young patients--report of two cases","volume":"12","author":"Katra","year":"2010","journal-title":"Diabetes Technol Ther."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20437474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20437474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/14566386722170G5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:56:28Z","timestamp":1761515788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20437474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1530891X20437474"],"URL":"https:\/\/doi.org\/10.4158\/ep13254.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mody-3: Novel HNF1A Mutation and the Utility of Glucagon-Like Peptide (GLP)-1 Receptor Agonist Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP13254.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}